⌕
Alto Neuroscience · ANRO · NYSE
Tenet 52 · Mixed
Compare
$27.12−8.19%At closeTenet 52 · Mixed
$27.12−2.42 (−8.19%)
At close: Nov 16, 2026, 4:00 PM ET· NYSE · USD

Alto Neuroscience (ANRO) Institutional Ownership

13F filers reported holding 73.7% of Alto Neuroscience (ANRO) shares as of Jun 30, 2026, across 116 filers.

Sources Ownership filingsQuarter ended How we compute thisNot investment advice

4 figures withheld by our checks. Each blank figure names its reason.

Held by 13F filers
73.7%
Jun 30, 2026
13F filers
116
quarter ended Jun 30, 2026
13F value
$780.4M
29.6M shares

Is the smart money (institutions and insiders) accumulating or distributing? One lagging input, not a buy signal.

13F fund flowQuarter ended Jun 30, 2026. Withheld: many filers have already reported a later quarter, so their changes in this quarter are not on file and the counts of new, added, trimmed and closed positions are not shown. These positions are 140 days old; the 45-day figure often quoted is the SEC filing deadline after quarter-end, not the age of the data. The counts above compare each filer’s position with its own previous 13F. The change in the number of filers and in the ownership share is not shown: the filings we read hold only each filer’s latest 13F, so there is no earlier quarter of the same filers to compare against. That is a limit of the source, not a statement about this company.
Basis: shares reported by 116 13F filers for Jun 30, 2026, over shares outstanding implied from the current quote, measured 140 days apart. It measures the ownership we have filings for, not total institutional ownership, and it moves with the share count between filings.
routine sells are usually compensation mechanics; open-market buys are the rarer signal. Rows labelled with another security are the derivative leg of a vest or exercise, not share sales
DateNameRoleTypeSharesPriceSEC filing
Oct 2, 2026Smith Nicholas ConradPRESIDENT AND CFOAcquired · Option exercise55,000$2.32↗
Oct 2, 2026Smith Nicholas ConradPRESIDENT AND CFODisposed · Option exercise55,000Employee Stock Option (Right to Buy)—↗
Sep 30, 2026Smith Nicholas ConradPRESIDENT AND CFOAcquired · Option exercise24,056$2.35↗
Sep 30, 2026Smith Nicholas ConradPRESIDENT AND CFODisposed · Open-market sale23,170$25.78↗
Sep 30, 2026Smith Nicholas ConradPRESIDENT AND CFODisposed · Open-market sale886$26.87↗
Sep 30, 2026Smith Nicholas ConradPRESIDENT AND CFODisposed · Option exercise24,056Employee Stock Option (Right to Buy)—↗
Sep 29, 2026Smith Nicholas ConradPRESIDENT AND CFOAcquired · Option exercise56,455$2.35↗
Sep 29, 2026Smith Nicholas ConradPRESIDENT AND CFOAcquired · Option exercise54,375$2.35↗
Sep 29, 2026Smith Nicholas ConradPRESIDENT AND CFODisposed · Open-market sale110,830$26.58↗
Sep 29, 2026Smith Nicholas ConradPRESIDENT AND CFODisposed · Option exercise56,455Employee Stock Option (Right to Buy)—↗
Sep 29, 2026Smith Nicholas ConradPRESIDENT AND CFODisposed · Option exercise54,375Employee Stock Option (Right to Buy)—↗
May 27, 2026Miller Andrew CraigdirectorAcquired · Grant / award26,000Stock Option (right to buy)—↗
May 14, 2026Etkin AmitPRESIDENT AND CEODisposed · Gift400,000—↗
May 12, 2026Manji HusseinidirectorAcquired · Grant / award10,958Stock Option (right to buy)—↗
May 12, 2026York GwilldirectorAcquired · Grant / award10,958Stock Option (right to buy)—↗
May 12, 2026Cox Christopher NixondirectorAcquired · Grant / award10,958Stock Option (right to buy)—↗
May 12, 2026Sanchez RamirodirectorAcquired · Grant / award10,958Stock Option (right to buy)—↗
May 12, 2026Dreyfus AndrewdirectorAcquired · Grant / award10,958Stock Option (right to buy)—↗
Mar 1, 2026Smith Nicholas ConradCHIEF FINANCIAL OFFICER & CBODisposed · Tax withholding2,806$19.69↗
Mar 1, 2026Etkin AmitPRESIDENT AND CEODisposed · Tax withholding6,227$19.69↗

* Holdings as reported for Jun 30, 2026, 140 days old; funds file up to 45 days after each quarter-end, so the newest complete quarter runs 45 to 135 days behind.

** A price of “—” marks an option exercise, RSU vest or a filing without a usable per-share price, not a $0 trade.

How much of Alto Neuroscience do institutions hold?

13F filers reported holding 73.7% of Alto Neuroscience's shares as of Jun 30, 2026, across 116 filers.

How many 13F filers hold Alto Neuroscience?

Alto Neuroscience was held by 116 13F filers as of Jun 30, 2026.

Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.